$2.92
+0.02
(+0.69%)▲
2.4%
Downside
Day's Volatility :3.72%
Upside
1.35%
28.77%
Downside
52 Weeks Volatility :52.07%
Upside
32.72%
Period | Oncocyte Corp | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | -4.26% | 0.2% | 0.0% |
6 Months | 5.42% | 4.6% | 0.0% |
1 Year | 31.53% | 15.3% | 0.0% |
3 Years | -95.89% | 11.3% | -27.4% |
Market Capitalization | 48.8M |
Book Value | $1.70 |
Earnings Per Share (EPS) | -4.28 |
PEG Ratio | 0.0 |
Wall Street Target Price | 4.13 |
Profit Margin | 0.0% |
Operating Margin TTM | -5445.19% |
Return On Assets TTM | -16.67% |
Return On Equity TTM | -101.76% |
Revenue TTM | 1.0M |
Revenue Per Share TTM | 0.11 |
Quarterly Revenue Growth YOY | -77.5% |
Gross Profit TTM | 188.0K |
EBITDA | -20.2M |
Diluted Eps TTM | -4.28 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -2.28 |
EPS Estimate Next Year | -1.73 |
EPS Estimate Current Quarter | -0.56 |
EPS Estimate Next Quarter | -0.55 |
What analysts predicted
Upside of 41.44%
Sell
Neutral
Buy
Oncocyte Corp is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Oncocyte Corp | -2.99% | 5.42% | 31.53% | -95.89% | -91.7% |
Idexx Laboratories, Inc. | -11.95% | -12.77% | -1.66% | -34.41% | 59.1% |
Agilent Technologies Inc. | -2.42% | -0.14% | 30.58% | -12.76% | 85.26% |
Thermo Fisher Scientific, Inc. | -6.36% | -2.22% | 23.25% | -10.2% | 90.38% |
Danaher Corp. | -6.96% | 1.08% | 27.9% | -17.02% | 85.43% |
Iqvia Holdings Inc. | -5.54% | -6.24% | 7.29% | -15.36% | 54.21% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Oncocyte Corp | NA | NA | 0.0 | -2.28 | -1.02 | -0.17 | NA | 1.7 |
Idexx Laboratories, Inc. | 40.05 | 40.05 | 4.37 | 10.55 | 0.59 | 0.23 | NA | 19.72 |
Agilent Technologies Inc. | 29.07 | 29.07 | 3.01 | 5.24 | 0.25 | 0.08 | 0.01 | 20.53 |
Thermo Fisher Scientific, Inc. | 34.96 | 34.96 | 2.09 | 21.69 | 0.13 | 0.05 | 0.0 | 128.08 |
Danaher Corp. | 46.73 | 46.73 | 2.9 | 7.5 | 0.08 | 0.04 | 0.0 | 71.03 |
Iqvia Holdings Inc. | 27.61 | 27.61 | 1.06 | 11.15 | 0.22 | 0.05 | NA | 38.37 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Oncocyte Corp | Buy | $48.8M | -91.7% | NA | 0.0% |
Idexx Laboratories, Inc. | Buy | $33.9B | 59.1% | 40.05 | 22.53% |
Agilent Technologies Inc. | Buy | $40.3B | 85.26% | 29.07 | 21.75% |
Thermo Fisher Scientific, Inc. | Buy | $213.4B | 90.38% | 34.96 | 14.48% |
Danaher Corp. | Buy | $179.0B | 85.43% | 46.73 | 16.39% |
Iqvia Holdings Inc. | Buy | $38.6B | 54.21% | 27.61 | 9.17% |
Insights on Oncocyte Corp
Revenue is down for the last 5 quarters, 463.0K → 104.0K (in $), with an average decrease of 29.8% per quarter
Netprofit is up for the last 3 quarters, -15.99M → -4.53M (in $), with an average increase of 88.4% per quarter
In the last 3 years, Oncocyte Corp has experienced a drawdown of -95.7%, however Thermo Fisher Scientific, Inc. resisted the overall trend and outperformed by 85.5%
BROADWOOD CAPITAL Inc
PURA VIDA INVESTMENTS, LLC
Vanguard Group Inc
Morgan Stanley - Brokerage Accounts
Geode Capital Management, LLC
BlackRock Inc
oncocyte is focused on the discovery, development, and commercialization of non-invasive, liquid biopsy diagnostics to facilitate clinical decision making in the early detection of cancer. the company's pipeline is focused on molecular tests for areas of high unmet need - lung, breast, and bladder cancers - where the current standard of diagnostic care is often ambiguous, costly, and involves invasive surgical procedures. oncocyte's diagnostics are developed based on a proprietary set of biomarkers that have been shown to differentiate benign from malignant nodules or masses. for more information, visit www.oncocyte.com.
Organization | Oncocyte Corp |
Employees | 43 |
CEO | Mr. Joshua Riggs |
Industry | Health Technology |
Cactus Acquisition Corp 1 Ltd
$2.92
+0.69%
Rigel Resource Acquisition Corp
$2.92
+0.69%
Everi Holdings Inc
$2.92
+0.69%
Anfield Us Equity Sector Rotation Etf
$2.92
+0.69%
Nordic American Tankers Limited
$2.92
+0.69%
3edge Dynamic Fixed Income Etf
$2.92
+0.69%
Direxion Daily Csi 300 China A Share 2x Shares Etf
$2.92
+0.69%
Dfa Dimensional Us Real Estate Etf
$2.92
+0.69%
Sow Good Inc
$2.92
+0.69%